Recent News
Brain metastasis persists despite improved targeted treatment for HER2 breast cancer
At this year's San Antonio Breast Cancer Symposium, UNC Lineberger researchers and collaborators shared the outcomes of their investigation into the incidence of brain metastasis after a series of drugs were approved to treat HER2-positive metastatic breast cancer, starting with trastuzumab, also known as Herceptin, in the United States in 1998.
Researchers developing model to predict if chemotherapy will work for aggressive breast cancer
In a study presented at the 2016 San Antonio Breast Cancer Symposium, UNC Lineberger researchers led by Katherine Hoadley, PhD, reported they developed a model that can predict which triple negative breast cancer patients will respond to chemotherapy.
Genetic alterations more common in tumors of older patients with metastatic breast cancer
In preliminary findings presented at the 2016 San Antonio Breast Cancer Symposium, researchers showed that older patients were as likely as younger patients to receive targeted therapy and enroll in therapeutic trials based on their sequencing results.
Thomas named chair of dermatology department
UNC Lineberger member Nancy Thomas, MD, PhD, has been named chair of the Department of Dermatology, effective Jan. 1.